$EXHI .0055 up 20% on NEWS! $EXHI is in the medical device
$EXHI .0055 up 20% on NEWS! $EXHI is in the medical device industry with a float of only 1.9M ~ the 52 week range is .0031 - .215 with no R/S! >>> Exlites Issues a Letter of Intent to Purchase a Medical Device Company http://www.stockwatch.com/News/Item.aspx?bid=...p;region=U 2013-11-18 07:01 ET - News Release Salt Lake City, UT, (eTeligis.com) Exlites Holdings International, Inc. (OTCPINK: EXHI) announced that it has issued a Letter of Intent ("LOI") to purchase a medical device company that will provide an existing sales force in proven markets with next generation products. Under the LOI, Exlites will provide use its stock to complete the acquisition and purchase 100% of the target company's issued and outstanding common stock, which will make the target company a wholly-owned subsidiary of Exlites. Exlites' CEO, Joseph Chung, stated that the acquisition should be completed within the next two weeks. The acquisition will increase the Company's product offerings and provide for new distribution channels and a seasoned sales force, Chung stated. Exlites was incorporated in the U.S., and until recently, was mainly engaged in business in Japan. Recently, management determined that it was in the Company's best interest to enter the larger U.S. medical equipment market and take advantage of its relationships. Exlites business model is unique in that the Company strives to provide assistance and resources to certain medical equipment manufacturers, many of whom are overseas, are more cost effective and may require FDA approval. By partnering with these medical equipment companies, Exlites can obtain better pricing for the best quality products for its customers. Exlites' business plan includes assisting manufacturers to obtain FDA registration and approval. About Exlites Holdings International Inc. Exlites Holdings International Inc. was operated in Japan for a number of years before moving to the United States. The Company's products are sold online and through the company's affiliate and distribution programs. The Company is dedicated to offering medical equipment to hospitals, assisted living facilities and to private individuals who seek quality medical equipment at cost effective prices. The Company's website is at http://www.exlitesmedical.com . CONTACT: Exlites Holdings International, Inc. info@exlitesmedical.com SOURCE: Exlites Holdings International, Inc. Chart: http://stockcharts.com/h-sc/ui?s=exhi
Corporate Website: http://www.exlitesmedical.com OTC Market Corporate Info: http://www.otcmarkets.com/stock/EXHI/quote
Scroll down for more posts ▼
Top 10 Most Recent News Articles
An Extra Helping of Community Spirit Rutter Mills is back on the scene again this Thanksgiving, slinging out a thousand turkeys to show their appreciation for the community they’ve called home since 1959. This initiative is the second iteration of their Turkey Drop, an event that's set to become a cherished tradition for years to come. Last year's event only teased the...
Continue Reading
A Shift in the MidCap 400: What's Up? Well, wouldn’t you know it, James Hardie Industries is making waves as it steps into the S&P MidCap 400. This move happens because Fox Corp. has nabbed Roku in a deal worthy of some popcorn. Come November 11, when the trading floor wakes up, James Hardie will be in and Roku will be out. Pretty neat switcheroo if you ask me. Inside...
Continue Reading
Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...
Continue Reading
Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....
Continue Reading
Deep Dive: Koppers' Financial Turmoil When a company throws a financial party, you don't expect the hangover to come in the form of an investigation notice. That’s what’s brewing over at Koppers Holdings Inc., leading many seasoned investors to take a hard, scrutinizing look at the books. The latest buzz? An inquiry into whether the company gave its investors the full...
Continue Reading
Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...
Continue Reading
Legal Storms Gather on Pinterest's Horizon I remember a time when Pinterest was the darling of Wall Street, but here we are, staring at an investigation that's got more layers than an onion. On November 6, 2026, news broke that Kahn Swick & Foti, LLC (KSF) is sniffing around Pinterest's officers and directors. This is no small fry since KSF is steered by none other than...
Continue Reading
What Tenax Investors Need to Know Alright, folks, time to pull up a chair and pay attention to what's brewing with Tenax Therapeutics—yeah, we're talking NASDAQ: TENX. The company's head is spinning as it's caught up in a securities class action lawsuit. What's the fuss? The fine print here accuses Tenax of misleading investors about the effectiveness of their product,...
Continue Reading
Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...
Continue Reading
Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...
Continue Reading
Top 5 Most Recently Viewed Articles
Alex Bastian Appointed as VP of Commercial Strategy at Memo Therapeutics AG Memo Therapeutics AG (or “MTx”), a late-stage biotech firm committed to transforming unique human immune responses into effective treatments for viral infections and cancer, has announced the appointment of Alex Bastian as its new VP of Commercial Strategy. Expertise in the Biotech Industry...
Continue Reading
AST SpaceMobile's New Partnership with the Space Development Agency AST SpaceMobile, Inc. (NASDAQ: ASTS), a pioneering company in the development of the world's first space-based cellular broadband network, has made a significant stride by securing an initial contract with the Space Development Agency (SDA). This selection as a prime contractor represents a substantial...
Continue Reading
Exploring the Growth of the CIP Chemicals Market The CIP Chemicals Market is on an exciting trajectory, with projections indicating remarkable growth in the coming years. Analysts anticipate that the market will expand from USD 2.40 billion in 2024 to an impressive USD 3.69 billion by the year 2029. This growth signals a compound annual growth rate (CAGR) of 9.0%,...
Continue Reading
Rocket Lab Partners with iQPS for Key Missions Rocket Lab USA, Inc. (Nasdaq: RKLB) has announced a significant contract with Institute for Q-shu Pioneers of Space, Inc. (iQPS), further solidifying its position as a leading provider of satellite launches. This new agreement includes three dedicated Electron missions, which will begin launching as early as 2026 from Rocket...
Continue Reading
Vinpai dropped its half-year numbers for 2024, and let me tell ya, it’s a mixed bag of good and bad. Sure, they reported a nice jump in sales—28% year-over-year to €5,111k—but you gotta dig deeper to see the cracks forming underneath that shiny surface. Revenue Growth vs. Margin Squeeze: What's the Real Deal? The revenue growth? That’s the feel-good story...
Continue Reading